A Pilot Trial Assessing Urinary Gene Expression Profiling with an mRNA Array for Diabetic Nephropathy
Authors:
Open Access
- 18 May 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (5) , e34824
Abstract
The initiation and progression of diabetic nephropathy (DN) is complex. Quantification of mRNA expression in urinary sediment has emerged as a novel strategy for studying renal diseases. Considering the numerous molecules involved in DN development, a high-throughput platform with parallel detection of multiple mRNAs is needed. In this study, we constructed a self-assembling mRNA array to analyze urinary mRNAs in DN patients with aims to reveal its potential in searching novel biomarkers. mRNA array containing 88 genes were fabricated and its performance was evaluated. A pilot study with 9 subjects including 6 DN patients and 3 normal controls were studied with the array. DN patients were assigned into two groups according to their estimate glomerular rate (eGFR): DNI group (eGFR>60 ml/min/1.73 m2, n = 3) and DNII group (eGFR2, n = 3). Urinary cell pellet was collected from each study participant. Relative abundance of these target mRNAs from urinary pellet was quantified with the array. The array we fabricated displayed high sensitivity and specificity. Moreover, the Cts of Positive PCR Controls in our experiments were 24±0.5 which indicated high repeatability of the array. A total of 29 mRNAs were significantly increased in DN patients compared with controls (p<0.05). Among these genes, α-actinin4, CDH2, ACE, FAT1, synaptopodin, COL4α, twist, NOTCH3 mRNA expression were 15-fold higher than those in normal controls. In contrast, urinary TIMP-1 mRNA was significantly decreased in DN patients (p<0.05). It was shown that CTGF, MCP-1, PAI-1, ACE, CDH1, CDH2 mRNA varied significantly among the 3 study groups, and their mRNA levels increased with DN progression (p<0.05). Our pilot study demonstrated that mRNA array might serve as a high-throughput and sensitive tool for detecting mRNA expression in urinary sediment. Thus, this primary study indicated that mRNA array probably could be a useful tool for searching new biomarkers for DN.Keywords
This publication has 24 references indexed in Scilit:
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathyNature Reviews Nephrology, 2011
- Diabetic kidney disease with and without albuminuriaCurrent Opinion in Nephrology and Hypertension, 2011
- Recent insights into diabetic renal injury from thedb/dbmouse model of type 2 diabetic nephropathyAmerican Journal of Physiology-Renal Physiology, 2011
- The Future of Diagnostic Gene-Expression Microarrays: Bridging The Gap Between Bench and BedsideBioanalysis, 2010
- A Real-Time PCR Array for Hierarchical Identification of Francisella IsolatesPLOS ONE, 2009
- Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathyCytokine, 2009
- Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathyDiabetologia, 2008
- A PAI-1 Mutant, PAI-1R, Slows Progression of Diabetic NephropathyJournal of the American Society of Nephrology, 2008
- Messenger RNA forFOXP3in the Urine of Renal-Allograft RecipientsNew England Journal of Medicine, 2005
- Podocytes that detach in experimental membranous nephropathy are viable11See Editorial by Mundel, p. 1529.Kidney International, 2003